On one end, in the tumor microenvironment, TF expression is highly detected on the cancer cells in cancer patients with a variety of solid cancer23, including both TNBC and non-TNBC, for example, 50–85% of patients with TNBC14 and 81–100% of patients with non-TNBC16,46,47. Here, TF is linked to cancer.